ArticleThe journal of gene medicine

Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.

Derek Leaderer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.